ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XENE Xenon Pharmaceuticals Inc

34.5591
0.4391 (1.29%)
Last Updated: 03:58:59
Delayed by 15 minutes

Xenon Pharmaceuticals Financial Summary

The current XENE market cap is 2.26B. The company's latest EPS is USD -1.9095 and P/E is -17.78.

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 536k132k000
Operating Income -30.32M-38.13M-43.33M-47.37M-53.67M
Net Income -31.16M-37.15M-36.96M-41.73M-47.46M
Year End 31 December 2022 20182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 06.83M32.17M18.44M9.43M
Operating Income -38.02M-42.82M-31.3M-78.99M-129.14M
Net Income -34.5M-41.6M-28.01M-77.09M-124.94M
Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 807.38M775.81M754.15M719.87M684.9M
Total Liabilities 21.59M22.69M32.65M32.92M38.44M
Total Equity 785.79M753.12M721.5M686.94M646.46M
Year End 31 December 2022 20182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 122.43M147.7M189.19M572.01M754.15M
Total Liabilities 19.13M55.72M17.83M21.97M32.65M
Total Equity 103.3M91.98M171.36M550.03M721.5M
Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -35.3M-65.7M-98.43M-34.41M-67.63M
Investing -47.57M-281.67M-296M46.62M74.52M
Financing 277.77M278.47M278.47M N/A N/A
Year End 31 December 2022 20182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -34.72M-4.63M-48.12M-69.5M-98.43M
Investing -28.99M-66.29M-16.82M-246.77M-296M
Financing 111.59M27.52M85.8M447.54M278.47M
Market Cap 2.26B
Price to Earnings Ratio -17.78
Price to Sales Ratio 235.44
Price to Cash Ratio 38.8
Price to Book Ratio 3.08
Dividend Yield -

Share Statistics

Shares Outstanding 65.43M
Average Volume (1 week) 1.19M
Average Volume (1 Month) 807.66k
52 Week Change -2.1%
52 Week High 43.75
52 Week Low 27.985
Spread (Intraday) 0.04 (0.12%)

Company Info

Company Name Xenon Pharmaceuticals Inc
Address 200 - 3650 gilmore way
burnaby, british columbia V5G 4W8
Website https://www.xenon-pharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com